Concepedia

Author

M Remacle-Bonnet

Centre National de la Recherche Scientifique

Also Known As

M M Remacle-Bonnet, M Remacle-Bonnet, M. M. Remacle-Bonnet, M. REMACLE-BONNET, M. REMACLE‐BONNET, M. Remacle-Bonnet, M.M. Remacle-Bonnet, Maryse M Remacle-Bonnet, Maryse M. Remacle-Bonnet, Maryse M. Remacle‐Bonnet

41

Publications

1K

Citations

18

H-Index

51

Concepts

All Affiliations

Centre National de la Recherche ScientifiqueHôpital Sainte-MargueriteCentre d’Immunologie de Marseille-LuminyInstitut de Neurobiologie de la MéditerranéeMécanismes de Tumorigenèse et Thérapies Ciblées
MR

About

M Remacle-Bonnet is an author at Centre National de la Recherche Scientifique specializing in medicine, cell biology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

609

2

Health Sciences

2

2

44

3

Engineering

1

1

42

4

Public Health

1

1

29

5

Biomolecular Engineering

1

1

42

M Remacle-Bonnet

×

25

Publications

966

Citations

18

H-Index

YearCitations

Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.

M Remacle-Bonnet, Françoise Garrouste, Scott Heller,

PubMed

2000

138

Alterations in serum levels of insulin‐like growth factors and insulin‐like growth‐factor‐binding proteins in patients with colorectal cancer

Fatima El Atiq, Françoise Garrouste, M Remacle-Bonnet,

International Journal of Cancer

1994

109

Protein kinases C-γ and -δ are involved in insulin-like growth factor I–induced migration of colonic epithelial cells

Frederic André, Véronique Rigot, M Remacle-Bonnet,

Gastroenterology

1999

73

Membrane Rafts Segregate Pro- from Anti-Apoptotic Insulin-Like Growth Factor-I Receptor Signaling in Colon Carcinoma Cells Stimulated by Members of the Tumor Necrosis Factor Superfamily

M Remacle-Bonnet, Françoise Garrouste, Gilbert Baillat,

American Journal Of Pathology

2005

71

Des‐(1–3)‐IGF‐I, an insulin‐like growth factor analog used to mimic a potential IGF‐II autocrine loop, promotes the differentiation of human colon‐carcinoma cells

M Remacle-Bonnet, Françoise Garrouste, Fatima El Atiq,

International Journal of Cancer

1992

49

Production of insulin‐like growth factor II (IGF‐II) and different forms of IGF‐binding proteins by HT‐29 human colon carcinoma cell line

Jean‐Michel Culouscou, M Remacle-Bonnet, Françoise Garrouste,

Journal of Cellular Physiology

1990

47

Deficient Processing and Activity of Type I Insulin-Like Growth Factor Receptor in the Furin-Deficient LoVo-C5 Cells*

Maxime Lehmann, Frederic André, Catherine Bellan,

Endocrinology

1998

47

Activation of Protein Tyrosine Kinases by<i>Coxiella burnetii</i>: Role in Actin Cytoskeleton Reorganization and Bacterial Phagocytosis

Sonia Meconi, Christian Capo, M Remacle-Bonnet,

Infection and Immunity

2001

46

Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.

G. Pommier, Françoise Garrouste, Fatima El Atiq,

PubMed

1992

42

Inhibition of Normal Allogenic Lymphocyte Mitogenesis by a Soluble Inhibitor Extracted from Human Colonic Carcinoma

M Remacle-Bonnet, Gilbert Pommier, S. Kaplanski,

The Journal of Immunology

1976

33

Page 1